Low-dose Interleukin-2 in the Treatment of Autoimmune Disease | touchONCOLOGY - 0 views
-
affect approximately 5 to 8 % of the US population
-
the incidence and prevalence of autoimmune diseases are rising
-
Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD) account for the majority of the patients with autoimmune diseases
- ...9 more annotations...
-
Great article. Immune dysfunction plays role in autoimmune disease and cancer. Treg cells sit at the center of autoimmunity. This artice highlights the different uses: low dose IL2 therapy to augment Tregs and reduce autoinflammation and high dose IL2 to augment Treg cells in the fight against cancer.